As of July 10, 2025, Chuang's Consortium International Ltd has a Discounted Cash Flow (DCF) derived fair value of $0.00 per share. With the current market price at $0.34, this represents a potential upside of -934.2%.
| Key Metrics | Value |
|---|---|
| DCF Fair Value (5-year) | $0.00 |
| DCF Fair Value (10-year) | $0.00 |
| Potential Upside (5-year) | -740.1% |
| Potential Upside (10-year) | -934.2% |
| Discount Rate (WACC) | 4.0% - 6.6% |
Revenue is projected to grow from $397 million in 03-2024 to $208 million by 03-2034, representing a compound annual growth rate of approximately -6.3%.
| Fiscal Year | Revenue (USD millions) | Growth |
|---|---|---|
| 03-2024 | 397 | 58% |
| 03-2025 | 170 | -57% |
| 03-2026 | 173 | 2% |
| 03-2027 | 177 | 2% |
| 03-2028 | 181 | 2% |
| 03-2029 | 185 | 2% |
| 03-2030 | 190 | 3% |
| 03-2031 | 194 | 2% |
| 03-2032 | 200 | 3% |
| 03-2033 | 204 | 2% |
| 03-2034 | 208 | 2% |
Net profit margin is expected to improve from -267% in 03-2024 to -228% by 03-2034, driven by operational efficiency and economies of scale.
| Fiscal Year | Net Profit (USD millions) | Profit Margin |
|---|---|---|
| 03-2024 | (1,059) | -267% |
| 03-2025 | (427) | -251% |
| 03-2026 | (426) | -246% |
| 03-2027 | (428) | -241% |
| 03-2028 | (428) | -236% |
| 03-2029 | (429) | -232% |
| 03-2030 | (439) | -231% |
| 03-2031 | (446) | -230% |
| 03-2032 | (459) | -229% |
| 03-2033 | (466) | -228% |
| 03-2034 | (474) | -228% |
with a 5-year average of $5 million. Projected CapEx is expected to maintain at approximately 1% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
| Fiscal Year | D&A (USD millions) |
|---|---|
| 03-2025 | 5 |
| 03-2026 | 2 |
| 03-2027 | 2 |
| 03-2028 | 1 |
| 03-2029 | 1 |
| 03-2030 | 1 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
| Components | Average Days |
|---|---|
| Days Receivables | 11 |
| Days Inventory | 2,136 |
| Days Payables | 11 |
| Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
|---|---|---|---|---|---|
| 6M/2025 | (63) | (12) | 1 | (234) | 182 |
| 2026 | (122) | (23) | 1 | (147) | 47 |
| 2027 | (116) | (23) | 1 | (97) | 3 |
| 2028 | (110) | (23) | 1 | 55 | (143) |
| 2029 | (104) | (23) | 1 | (57) | (24) |
| Valuation Method | Fair Price (USD) | Potential Upside |
|---|---|---|
| 5-Year DCF (Growth) | 0.00 | -740.1% |
| 10-Year DCF (Growth) | 0.00 | -934.2% |
| 5-Year DCF (EBITDA) | 0.00 | -100.0% |
| 10-Year DCF (EBITDA) | 0.00 | -100.0% |
Is Chuang's Consortium International Ltd (367.HK) a buy or a sell? Chuang's Consortium International Ltd is definitely a sell. Based on our DCF analysis, Chuang's Consortium International Ltd (367.HK) appears to be overvalued with upside potential of -934.2%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $0.34.